Holen Sie sich die Stockscreener-App
1.965
0.76%
-0.015
Schlusskurs vom Vortag:
$1.98
Offen:
$1.98
24-Stunden-Volumen:
96,208
Relative Volume:
0.15
Marktkapitalisierung:
$149.73M
Einnahmen:
$151.64M
Nettoeinkommen (Verlust:
$-37.23M
KGV:
-3.5963
EPS:
-0.5464
Netto-Cashflow:
$-13.58M
1W Leistung:
+4.24%
1M Leistung:
-31.05%
6M Leistung:
+31.00%
1J Leistung:
-31.77%
1-Tages-Spanne:
$1.965
$2.01
1-Wochen-Bereich:
$1.84
$2.02
52-Wochen-Spanne:
$0.80
$3.44
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.965 | 149.73M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
98.61 | 170.62B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.39 | 119.46B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.48 | 112.95B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.14 | 63.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 50.56B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-11 | Eingeleitet | B. Riley Securities | Buy |
| 2026-07-20 | Eingeleitet | BTIG Research | Buy |
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics (NasdaqGM:STIM) Stock Forecast & Analyst Predictions - Simply Wall Street
STIM Looks 73.9% Overvalued on GF Value™ - GuruFocus
Neuronetics a new buy at B Riley on interventional psychiatry platform - Seeking Alpha
STIM Initiated Coverage On by B. Riley Securities -- Rating Set to Buy - GuruFocus
Neuronetics stock gains after B.Riley initiates coverage at Buy By Investing.com - Investing.com South Africa
Neuronetics stock gains after B.Riley initiates coverage at Buy - investing.com
B.Riley initiates Neuronetics stock coverage with buy rating - investing.com
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System - Investing News Network
Neuronetics, Inc. Integrates TrakStar With AdvancedMD, Inc. To Deliver TMS Care Across Clinical, Operational, And Billing Workflows - marketscreener.com
A magnetic brain-treatment system links to patient records for the first time - Stock Titan
Neuronetics (STIM) Slips 2.46% to $2.77 as Key Support LoomsSystematic Flow - vinanet.vn
Neuronetics (NASDAQ: STIM) backer spent about $20.7M of his own cash - Stock Titan
Neuronetics (STIM) Results Breakdown: The Available Earnings Metric Delivers a Beat in the Current Update; After Results: The Market Price Declines 1.59% in Latest TradingEarnings Miss Streak - vinanet.vn
Neuronetics (NASDAQ: STIM) ex-officer lines up $464K stock sale - Stock Titan
Neuronetics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neuronetics Expands CFO Nir Naor’s Financial Leadership Role - The Globe and Mail
Neuronetics (NASDAQ: STIM) holder plans $388K sale with part for taxes - Stock Titan
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - AOL.com
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - The Globe and Mail
Neuronetics (STIM) Edges Lower by 0.91% as Shares Navigate Key Support at $3.11Volume Weighted Price - vinanet.vn
Neuronetics (STIM) Slips to $3.25 as Shares Hover Near Key SupportPairs Trade - vinanet.vn
Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock - MarketBeat
Neuronetics director Jorey Chernett buys $44,240 in company stock - Investing.com
Neuronetics director Jorey Chernett buys $44,240 in company stock By Investing.com - Investing.com Canada
Neuronetics 10% owner Jorey Chernett acquires 14,000 common shares worth $44,240 - Bitget
Neuronetics (STIM) 10% holder buys stock, exits call options - Stock Titan
Neuronetics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chernett Jorey - Moomoo
Neuronetics Stock Price Forecast. Should You Buy STIM? - StockInvest.us
Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - Stock Titan
US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st
Neuronetics Q2 2026 Results: Hybrid NeuroStar Model and Greenbrook Growth Signal Strategic PivotEarnings Preview - Vinanet
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Neuronetics (STIM) Stock Repriced After Margin Gains And EBITDA Breakeven - Sahm
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Canada
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Reven - GuruFocus
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... - Yahoo Finance
Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants - Stock Titan
STIM Maintained by BTIG -- Price Target Raised to $6.00 - GuruFocus
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Nigeria
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Canada
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Canada
BTIG Research Forecasts Strong Price Appreciation for Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com UK
Neuronetics Q2 2026 slides: mental health platform beats on margins By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Australia
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neuronetics Inc-Aktie (STIM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | Officer |
Aug 18 '26 |
Proposed Sale |
3.21 |
121,033 |
388,274 |
0 |
| Chernett Jorey | 10% Owner |
Aug 14 '26 |
Buy |
3.16 |
14,000 |
44,240 |
10,602,988 |
| Chernett Jorey | 10% Owner |
Jul 14 '26 |
Buy |
1.78 |
35,000 |
62,300 |
10,588,988 |
| Sullivan Keith J | Former Officer and Director |
Jun 08 '26 |
Proposed Sale |
1.29 |
42,164 |
54,345 |
0 |
| Chernett Jorey | 10% Owner |
May 19 '26 |
Buy |
1.17 |
100,000 |
117,000 |
10,553,988 |
| Chernett Jorey | 10% Owner |
May 12 '26 |
Buy |
1.34 |
475,000 |
636,500 |
10,453,988 |
| Chernett Jorey | 10% Owner |
Apr 21 '26 |
Buy |
1.51 |
100,000 |
151,000 |
9,978,988 |
| Chernett Jorey | 10% Owner |
Apr 20 '26 |
Buy |
1.58 |
100,000 |
158,000 |
9,878,988 |
| Chernett Jorey | 10% Owner |
Mar 30 '26 |
Buy |
1.25 |
385,442 |
481,802 |
9,778,988 |
| Chernett Jorey | 10% Owner |
Mar 27 '26 |
Buy |
1.35 |
500,000 |
675,000 |
9,393,276 |
5.24%
1.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):